Orbimed Advisors LLC Neuro Pace Inc Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,406,335 shares of NPCE stock, worth $37.5 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
3,406,335
Previous 3,406,335
-0.0%
Holding current value
$37.5 Million
Previous $23.7 Million
60.54%
% of portfolio
1.03%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
65Shares Held
21.7MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$58 Million78.74% of portfolio
-
Morgan Stanley New York, NY2.49MShares$27.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$26.8 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$16.3 Million7.02% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$12.6 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $273M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...